(a) the details of pricing norms fixed for sale of drugs and medicines along with mechanism in place to penalise those violating the pricing norms;
(b) whether a number of drug companies including MNCs, have reportedly been found to be overcharging the customers recently, if so, the details of such companies and action taken thereon;
(c) whether the National Pharmaceutical Pricing Authority (NPPA) has proposed some changes in the existing Drug Price Control Order, 2013 so as to arm itself with powers to impose fine on those violating pricing norms and if so, the details thereof;
(d) whether the Government has taken on board various stakeholders including industry representatives from the civil society and public health groups to deliberate on the proposal; and
(e) if so, the details thereof and the response of the different stakeholders in this regard?